Athens-Limestone Hospital is is expanding its sleep treatment options with the addition of a therapy that can serve as an alternative to CPAP devices for moderate to severe sleep apnea […] ...

Studies in mice reveal a new target for potentially treating and preventing life-threatening cardiovascular complications in ...

ResMed Inc. (NYSE:RMD) develops and manufactures medical devices and digital health solutions for sleep apnea, chronic ...

Sleep apnea becomes substantially more severe on weekends compared to weekdays, and the effect is amplified in people who ...

INSIDE INFORMATIONREGULATED INFORMATIONNyxoah Announces Pricing of $95 Million Underwritten Public OfferingMont-Saint-Guibert, Belgium – June 5, ...

In addition, the agreement includes commitments from Streeterville to suspend any calls for repayments of its debt and any sales of Company securities for 90 and 60 days, respectively, from the date ...

If you're writing these symptoms off as stress, it might be time to look closer: Chronic daytime fatigue (despite 8 hours of ...

ResMed (RMD) outlines growth catalysts in sleep & breathing health: AI, wearables, GLP-1 tailwinds, COPD, and Noctrix RLS deal—read key takeaways now.

A LM is a safe alternative to TT intubation for pediatric patients with obstructive sleep apnea undergoing adenotonsillectomies.

A popular antipsychotic medication was found to reduce obstructive sleep apnea (OSA) – but it also led to impaired driving the next morning. That’s according to a small randomized controlled trial ...

Outgoing Nyxoah CEO Olivier Taelman [Image from LinkedIn] Nyxoah announced today that it plans to move on from current CEO Olivier Taelman and begin a search for a new chief executive.

Many people struggle to get a good night’s sleep. Insomnia affects millions of adults and can leave people feeling tired, ...